2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $13B | $14B | $15B | $9.8B | $10B |
Cost of Revenue | $8.3B | $8.7B | $8.8B | $6.1B | $6.3B |
Gross Profit | $4.2B | $5.2B | $5.7B | $3.7B | $3.8B |
Gross Profit % | 33% | 37% | 39% | 37% | 38% |
R&D Expenses | $0 | $0 | $0 | $0 | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | $164M | $424M | -$17B | $499M | $1.5B |
Dep. & Amort. | $3.7B | $4B | $3.8B | $2.7B | $1.7B |
Def. Tax | -$206M | -$81M | -$544M | -$705M | $0 |
Stock Comp. | $283M | $383M | $215M | $154M | $186M |
Chg. in WC | $311M | -$464M | -$557M | -$134M | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $2B | $2B | $2.2B | $440M | $834M |
ST Investments | $0 | $0 | $0 | $0 | -$796M |
Cash & ST Inv. | $2B | $2B | $2.2B | $440M | $38M |
Receivables | $3.3B | $3.8B | $2B | $2.2B | $3M |
Inventory | $3.3B | $551M | $0 | $0 | $0 |
FIS reported a 4% revenue growth in 2024, slightly below expectations due to one-time items, but anticipates acceleration to 4.6%-5.2% in 2025, driven by strong ACV sales and deferred implementations.
Adjusted EPS grew 18% in 2024, exceeding the full-year outlook, with a projected growth of 9%-11% in 2025. Margin expansion of 40-45 basis points is expected for 2025.
The company returned $4 billion to shareholders in 2024 and plans to return $2 billion in 2025, including $1.2 billion in share repurchases.
Banking revenue is projected to grow 3.7%-4.4% in 2025, with recurring revenue growing slightly faster. Capital Markets is expected to grow 6.5%-7%, supported by acquisitions like Demica.
Free cash flow conversion is guided at 82%-85% for 2025, with improvements expected from better working capital management and reduced capital expenditures.